vs

Side-by-side financial comparison of Carlyle Group Inc. (CG) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

Carlyle Group Inc. is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.4× PACS Group, Inc.). Carlyle Group Inc. runs the higher net margin — 18.8% vs 4.4%, a 14.4% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 18.4%). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs 20.5%).

The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.

CG vs PACS — Head-to-Head

Bigger by revenue
CG
CG
1.4× larger
CG
$1.9B
$1.4B
PACS
Growing faster (revenue YoY)
CG
CG
+65.7% gap
CG
84.1%
18.4%
PACS
Higher net margin
CG
CG
14.4% more per $
CG
18.8%
4.4%
PACS
Faster 2-yr revenue CAGR
CG
CG
Annualised
CG
66.2%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CG
CG
PACS
PACS
Revenue
$1.9B
$1.4B
Net Profit
$358.1M
$59.7M
Gross Margin
Operating Margin
24.3%
7.0%
Net Margin
18.8%
4.4%
Revenue YoY
84.1%
18.4%
Net Profit YoY
69.8%
3022.5%
EPS (diluted)
$0.96
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CG
CG
PACS
PACS
Q4 25
$1.9B
$1.4B
Q3 25
$332.7M
$1.3B
Q2 25
$1.6B
$1.3B
Q1 25
$973.1M
$1.3B
Q4 24
$1.0B
$1.1B
Q3 24
$2.6B
$1.0B
Q2 24
$1.1B
$981.4M
Q1 24
$688.4M
$934.3M
Net Profit
CG
CG
PACS
PACS
Q4 25
$358.1M
$59.7M
Q3 25
$900.0K
$52.4M
Q2 25
$319.7M
$51.0M
Q1 25
$130.0M
$28.5M
Q4 24
$210.9M
$1.9M
Q3 24
$595.7M
$15.6M
Q2 24
$148.2M
$-10.9M
Q1 24
$65.6M
$49.1M
Gross Margin
CG
CG
PACS
PACS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
17.1%
Q2 24
22.3%
Q1 24
21.2%
Operating Margin
CG
CG
PACS
PACS
Q4 25
24.3%
7.0%
Q3 25
25.8%
6.4%
Q2 25
28.0%
6.2%
Q1 25
17.6%
3.8%
Q4 24
25.7%
1.7%
Q3 24
29.9%
2.2%
Q2 24
20.5%
0.1%
Q1 24
17.5%
8.6%
Net Margin
CG
CG
PACS
PACS
Q4 25
18.8%
4.4%
Q3 25
0.3%
3.9%
Q2 25
20.3%
3.9%
Q1 25
13.4%
2.2%
Q4 24
20.4%
0.2%
Q3 24
22.6%
1.5%
Q2 24
13.9%
-1.1%
Q1 24
9.5%
5.3%
EPS (diluted)
CG
CG
PACS
PACS
Q4 25
$0.96
$0.42
Q3 25
$0.00
$0.32
Q2 25
$0.87
$0.31
Q1 25
$0.35
$0.17
Q4 24
$0.56
$-0.03
Q3 24
$1.63
$0.10
Q2 24
$0.40
$-0.07
Q1 24
$0.18
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CG
CG
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$2.0B
$197.0M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$7.1B
$946.8M
Total Assets
$29.1B
$5.6B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CG
CG
PACS
PACS
Q4 25
$2.0B
$197.0M
Q3 25
$2.2B
$355.7M
Q2 25
$1.3B
$294.2M
Q1 25
$1.2B
$287.5M
Q4 24
$1.3B
$157.7M
Q3 24
$1.4B
$49.5M
Q2 24
$914.8M
$73.4M
Q1 24
$1.3B
$81.2M
Total Debt
CG
CG
PACS
PACS
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CG
CG
PACS
PACS
Q4 25
$7.1B
$946.8M
Q3 25
$6.8B
$871.3M
Q2 25
$6.7B
$806.8M
Q1 25
$6.4B
$750.2M
Q4 24
$6.3B
$709.6M
Q3 24
$6.3B
$660.0M
Q2 24
$5.7B
$572.1M
Q1 24
$5.7B
$128.0M
Total Assets
CG
CG
PACS
PACS
Q4 25
$29.1B
$5.6B
Q3 25
$27.1B
$5.6B
Q2 25
$25.1B
$5.5B
Q1 25
$24.1B
$5.5B
Q4 24
$23.1B
$5.2B
Q3 24
$22.7B
$4.5B
Q2 24
$22.3B
$3.9B
Q1 24
$20.8B
$3.9B
Debt / Equity
CG
CG
PACS
PACS
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CG
CG
PACS
PACS
Operating Cash FlowLast quarter
$-1.2B
$-3.4M
Free Cash FlowOCF − Capex
$-1.2B
FCF MarginFCF / Revenue
-65.1%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
-3.34×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$-3.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CG
CG
PACS
PACS
Q4 25
$-1.2B
$-3.4M
Q3 25
$-1.6B
$204.8M
Q2 25
$-168.8M
$52.6M
Q1 25
$-352.1M
$150.2M
Q4 24
$-352.8M
$64.6M
Q3 24
$791.9M
$209.2M
Q2 24
$-1.3B
$34.8M
Q1 24
$71.1M
$58.8M
Free Cash Flow
CG
CG
PACS
PACS
Q4 25
$-1.2B
Q3 25
$-1.6B
Q2 25
$-186.3M
Q1 25
$-368.8M
Q4 24
$-379.5M
Q3 24
$772.8M
Q2 24
$-1.3B
Q1 24
$56.9M
FCF Margin
CG
CG
PACS
PACS
Q4 25
-65.1%
Q3 25
-475.7%
Q2 25
-11.8%
Q1 25
-37.9%
Q4 24
-36.8%
Q3 24
29.3%
Q2 24
-120.4%
Q1 24
8.3%
Capex Intensity
CG
CG
PACS
PACS
Q4 25
2.2%
Q3 25
7.0%
Q2 25
1.1%
Q1 25
1.7%
Q4 24
2.6%
Q3 24
0.7%
Q2 24
1.7%
Q1 24
2.1%
Cash Conversion
CG
CG
PACS
PACS
Q4 25
-3.34×
-0.06×
Q3 25
-1732.78×
3.91×
Q2 25
-0.53×
1.03×
Q1 25
-2.71×
5.28×
Q4 24
-1.67×
33.78×
Q3 24
1.33×
13.39×
Q2 24
-8.57×
Q1 24
1.08×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CG
CG

Fund Management Fee$606.8M32%
Other$528.7M28%
Global Private Equity Segment$307.3M16%
Global Credit Segment$238.0M13%
Carlyle Alp Invest Segment$124.6M7%
Incentive Fee$55.4M3%
Fee Related Performance Revenues$29.2M2%
Investment Advice$11.1M1%

PACS
PACS

Segment breakdown not available.

Related Comparisons